DK1309607T3 - Fremgangsmåde til fremstilling af LHRH-antagonister - Google Patents
Fremgangsmåde til fremstilling af LHRH-antagonisterInfo
- Publication number
- DK1309607T3 DK1309607T3 DK01978273T DK01978273T DK1309607T3 DK 1309607 T3 DK1309607 T3 DK 1309607T3 DK 01978273 T DK01978273 T DK 01978273T DK 01978273 T DK01978273 T DK 01978273T DK 1309607 T3 DK1309607 T3 DK 1309607T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- lhrh antagonists
- lhrh
- antagonists
- Prior art date
Links
- 229940124041 Luteinizing hormone releasing hormone (LHRH) antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10040700A DE10040700A1 (de) | 2000-08-17 | 2000-08-17 | Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung |
| PCT/EP2001/009219 WO2002014347A2 (de) | 2000-08-17 | 2001-08-09 | Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen |
| CA002355573A CA2355573A1 (en) | 2000-08-17 | 2001-08-22 | Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1309607T3 true DK1309607T3 (da) | 2005-01-17 |
Family
ID=27805895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01978273T DK1309607T3 (da) | 2000-08-17 | 2001-08-09 | Fremgangsmåde til fremstilling af LHRH-antagonister |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6780972B2 (da) |
| EP (1) | EP1309607B1 (da) |
| JP (1) | JP2004506647A (da) |
| CN (1) | CN1187369C (da) |
| AR (1) | AR030371A1 (da) |
| AT (1) | ATE280779T1 (da) |
| AU (2) | AU1043902A (da) |
| BG (1) | BG107612A (da) |
| BR (1) | BR0113296A (da) |
| CA (1) | CA2355573A1 (da) |
| CZ (1) | CZ2003688A3 (da) |
| DE (2) | DE10040700A1 (da) |
| DK (1) | DK1309607T3 (da) |
| EE (1) | EE200300065A (da) |
| ES (1) | ES2230371T3 (da) |
| HK (1) | HK1058366A1 (da) |
| HU (1) | HUP0300738A3 (da) |
| IL (1) | IL154150A0 (da) |
| MX (1) | MXPA03001448A (da) |
| NO (1) | NO20030618L (da) |
| NZ (1) | NZ524023A (da) |
| PL (1) | PL204496B1 (da) |
| PT (1) | PT1309607E (da) |
| RU (1) | RU2266296C2 (da) |
| SI (1) | SI1309607T1 (da) |
| SK (1) | SK3032003A3 (da) |
| TW (1) | TWI236910B (da) |
| UA (1) | UA74005C2 (da) |
| WO (1) | WO2002014347A2 (da) |
| ZA (1) | ZA200300777B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
| US7098305B2 (en) * | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
| EP1674082A1 (de) * | 2004-12-22 | 2006-06-28 | Zentaris GmbH | Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel |
| RU2525661C2 (ru) * | 2012-11-15 | 2014-08-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) | Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин |
| CN107056894B (zh) * | 2017-05-26 | 2021-07-20 | 济南康和医药科技有限公司 | 一种片段法固相合成醋酸加尼瑞克的方法 |
| EP3590526A1 (en) * | 2018-07-05 | 2020-01-08 | Antev Limited | A lyophilization process and a teverelix-tfa lyophilizate obtained thereby |
| CN114249800A (zh) * | 2020-09-22 | 2022-03-29 | 深圳市星银医药有限公司 | 一种双羟萘酸多肽药物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431635A (en) * | 1979-06-13 | 1984-02-14 | Coy David Howard | LH-RH Antagonists |
| ATE8988T1 (de) * | 1980-06-02 | 1984-09-15 | Andrew Victor Schally | Lh-rh antagonisten. |
| US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
| DE4305225A1 (de) * | 1993-02-19 | 1994-08-25 | Asta Medica Ag | Neues Herstellverfahren für Cetrorelix Lyophilisat |
| EP0626170A3 (en) * | 1993-05-10 | 1996-03-27 | Sandoz Ltd | Stabilization of pharmacoligically active compounds in controlled release compositions. |
| CA2178592C (en) * | 1993-12-09 | 2009-07-28 | Jurgen Engel | Long-acting injection suspensions and a process for their preparation |
| DE4342092B4 (de) * | 1993-12-09 | 2007-01-11 | Zentaris Gmbh | Langwirkende Injektionssuspension und Verfahren zur Herstellung |
| US6054432A (en) * | 1996-09-12 | 2000-04-25 | Asta Medica Aktiengesellschaft | Means for treating prostate hypertrophy and prostate cancer |
| US6740634B1 (en) * | 1998-01-16 | 2004-05-25 | Takeda Chemical Industries, Ltd. | Sustained release compositions, process for producing the same and utilization thereof |
-
2000
- 2000-08-17 DE DE10040700A patent/DE10040700A1/de not_active Withdrawn
-
2001
- 2001-08-09 SK SK303-2003A patent/SK3032003A3/sk not_active Application Discontinuation
- 2001-08-09 PT PT01978273T patent/PT1309607E/pt unknown
- 2001-08-09 AT AT01978273T patent/ATE280779T1/de not_active IP Right Cessation
- 2001-08-09 AU AU1043902A patent/AU1043902A/xx active Pending
- 2001-08-09 EE EEP200300065A patent/EE200300065A/xx unknown
- 2001-08-09 DE DE50104316T patent/DE50104316D1/de not_active Expired - Lifetime
- 2001-08-09 ES ES01978273T patent/ES2230371T3/es not_active Expired - Lifetime
- 2001-08-09 MX MXPA03001448A patent/MXPA03001448A/es active IP Right Grant
- 2001-08-09 CN CNB018142192A patent/CN1187369C/zh not_active Expired - Fee Related
- 2001-08-09 CZ CZ2003688A patent/CZ2003688A3/cs unknown
- 2001-08-09 JP JP2002519484A patent/JP2004506647A/ja active Pending
- 2001-08-09 RU RU2003107560/04A patent/RU2266296C2/ru not_active IP Right Cessation
- 2001-08-09 IL IL15415001A patent/IL154150A0/xx not_active IP Right Cessation
- 2001-08-09 EP EP01978273A patent/EP1309607B1/de not_active Expired - Lifetime
- 2001-08-09 NZ NZ524023A patent/NZ524023A/en unknown
- 2001-08-09 PL PL359495A patent/PL204496B1/pl not_active IP Right Cessation
- 2001-08-09 BR BR0113296-2A patent/BR0113296A/pt not_active IP Right Cessation
- 2001-08-09 DK DK01978273T patent/DK1309607T3/da active
- 2001-08-09 HU HU0300738A patent/HUP0300738A3/hu unknown
- 2001-08-09 SI SI200130237T patent/SI1309607T1/xx unknown
- 2001-08-09 WO PCT/EP2001/009219 patent/WO2002014347A2/de active IP Right Grant
- 2001-08-09 AU AU2002210439A patent/AU2002210439B2/en not_active Ceased
- 2001-08-16 AR ARP010103935A patent/AR030371A1/es active IP Right Grant
- 2001-08-17 TW TW090120293A patent/TWI236910B/zh active
- 2001-08-22 CA CA002355573A patent/CA2355573A1/en not_active Abandoned
- 2001-08-24 US US09/939,532 patent/US6780972B2/en not_active Expired - Fee Related
- 2001-09-08 UA UA2003032260A patent/UA74005C2/uk unknown
-
2003
- 2003-01-29 ZA ZA200300777A patent/ZA200300777B/xx unknown
- 2003-02-07 NO NO20030618A patent/NO20030618L/no unknown
- 2003-03-06 BG BG107612A patent/BG107612A/bg unknown
-
2004
- 2004-02-13 HK HK04101030A patent/HK1058366A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
| DK1326585T3 (da) | Fremgangsmåde til fremstilling af pulverformuleringer | |
| CY2007029I2 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| DK1296656T3 (da) | Fremgangsmåde til fremstilling af et præparat | |
| CY2013011I2 (el) | Μεθοδος χορηγησης διφωσφονικων | |
| DK1257954T3 (da) | Fremgangsmåde til fordeling af forsendelser | |
| DK1309545T3 (da) | Fremgangsmåde til fremstilling af alkylarylsulfonater | |
| DK1132570T3 (da) | Sammensætninger til syrebehandling af borebrönde | |
| DK1309555T3 (da) | Metode til fremstilling af amlodipinmaleat | |
| DK1309581T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
| DK1147075T3 (da) | Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid | |
| DK1345939T3 (da) | Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner | |
| DK1263717T3 (da) | Fremgangsmåde til fremstilling af methionin | |
| DK1326836T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin | |
| DK1456229T3 (da) | Fremgangsmåe til fremstilling af echinocandin-derivater | |
| DK1296970T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
| DK1292586T3 (da) | Fremgangsmåde til fremstilling af pyrazolopyrimidinoner | |
| DK1309607T3 (da) | Fremgangsmåde til fremstilling af LHRH-antagonister | |
| IS2725B (is) | Inndælingarlausn sem samanstendur af LHRH mótlyfi | |
| DK1299181T3 (da) | Fremgangsmåde til fremstilling af formaldehyd | |
| DK1203000T3 (da) | Fremgangsmåde til fremstilling af phosphonomethylglycin | |
| DK1294694T3 (da) | Fremgangsmåde til fremstilling af quinolinderivater | |
| DK1591122T3 (da) | Fremgangsmåde til indgivelse af bisphosphonater | |
| DK1272486T3 (da) | Fremgangsmåde til fremstilling af 7-(pyrazol-3-yl)benzoxazoler | |
| DK1254159T3 (da) | Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider |